Literature DB >> 12587912

On biologically conformal boost dose optimization.

M Alber1, F Paulsen, S M Eschmann, H J Machulla.   

Abstract

A method is described that allows the inclusion of biological imaging data in the optimization of intensity-modulated radiotherapy to produce dose boosts that conform with target subvolumes of potentially reduced radiosensitivity. The biological image (e.g. PET, fMRI, etc) is transformed into a dose efficiency distribution using a piecewise linear calibration function with a prescribed maximum boost factor. Instead of dose alone, the cost function of the optimization algorithm depends on the product of the physical dose times dose efficiency. An example case of a base-of-tongue tumour which was imaged with the hypoxia tracer fluoro-misonidazole is presented, showing the excellent capability of IMRT to produce dose distributions that conform to spatially variable dose prescriptions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12587912     DOI: 10.1088/0031-9155/48/2/404

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  29 in total

1.  A phantom model demonstration of tomotherapy dose painting delivery, including managed respiratory motion without motion management.

Authors:  Michael W Kissick; Xiaohu Mo; Keisha C McCall; Leah K Schubert; David C Westerly; Thomas R Mackie
Journal:  Phys Med Biol       Date:  2010-04-30       Impact factor: 3.609

2.  18F-FET-PET-based dose painting by numbers with protons.

Authors:  Mark Rickhey; Zdenek Morávek; Christoph Eilles; Oliver Koelbl; Ludwig Bogner
Journal:  Strahlenther Onkol       Date:  2010-05-21       Impact factor: 3.621

Review 3.  Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.

Authors:  Avraham Eisbruch; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2009-01       Impact factor: 5.934

4.  Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients.

Authors:  Stephen R Bowen; Jatinder Saini; Tobias R Chapman; Robert S Miyaoka; Paul E Kinahan; George A Sandison; Tony Wong; Hubert J Vesselle; Matthew J Nyflot; Smith Apisarnthanarax
Journal:  Radiother Oncol       Date:  2015-04-28       Impact factor: 6.280

5.  Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study.

Authors:  R T Flynn; D L Barbee; T R Mackie; R Jeraj
Journal:  Phys Med Biol       Date:  2007-10-01       Impact factor: 3.609

Review 6.  Molecular imaging of tumor hypoxia with positron emission tomography.

Authors:  Olivia J Kelada; David J Carlson
Journal:  Radiat Res       Date:  2014-03-27       Impact factor: 2.841

Review 7.  Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive?

Authors:  Vincent Grégoire; Robert Jeraj; John Aldo Lee; Brian O'Sullivan
Journal:  Lancet Oncol       Date:  2012-06-28       Impact factor: 41.316

8.  Parametric mapping of [18F]fluoromisonidazole positron emission tomography using basis functions.

Authors:  Young T Hong; John S Beech; Rob Smith; Jean-Claude Baron; Tim D Fryer
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

Review 9.  Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription.

Authors:  Søren M Bentzen; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

10.  On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function.

Authors:  Stephen R Bowen; Ryan T Flynn; Søren M Bentzen; Robert Jeraj
Journal:  Phys Med Biol       Date:  2009-02-13       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.